FM crss. PPS score 40 %. Upto April 29

 

Palliative Performance Scale

• Population: Patients who have received a palliative care consultation at an academic medical center. If your patient is in hospice, use the hospice version of the PPS by clicking here.
• Outcome: 1-month mortality, 6-month mortality, median survival in months.
• Scroll to the bottom for more detailed information

The PPS is 40%.

Outpatients with Non-Cancer Diagnoses
PPS	1-month mortality, %	6-month mortality, %	Median survival (95% CI) in months
10% - 30%	14.6%	32.7%	21.9 (6.8 to ≥30.0) months
40%	10.4%	27.1%	≥30.0 (17.7 to ≥30.0) months
50%	3.6%	21.6%	28.6 (17.9 to ≥30.0) months
60%	3.1%	17.3%	≥30.0 (23.8 to ≥30.0) months
70%	0.5%	10.4%	≥30.0 (≥30.0 to ≥30.0) months
80% - 100%	0.0%	4.6%	≥30.0 (≥30.0 to ≥30.0) months

* CI = confidence interval

• The Palliative Performance Scale (PPS) has been shown to be valid and useful for a broad range of palliative care patients: Those with advanced cancer and life-threatening non-cancer diagnoses in inpatient and outpatient palliative care settings.¹
• Prognostic estimates shown are from an external validation study done in 4779 patients who received a palliative care consult at the University of California, San Francisco between 1/1/2018 and 12/31/2020.
• Average age was 63 years, 51% women, 57% white.
• Among inpatients, 62.3% had cancer, 5.1% had neurologic illnesses, and 32.6% had other serious illnesses. Among outpatients, 73.9% had cancer, 11.9% had neurologic illnesses, and 14.2% had other serious illnesses.
• This risk calculator has good ability to sort patients who lived from patients who died at 1-month and moderate ability to sort patients who lived from patients who died at 6-months and longer follow-up.
• Discrimination for mortality at 1 month: